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Abstract 
Background: Afghan refugees in northern Pakistan have been resident for over 30 years and current information 
on malaria in this population is sparse. Understanding malaria risk and distribution in refugee camps is important for 
effective management both in camps and on return to Afghanistan.
Methods: Cross-sectional malariometric surveys were conducted in five Afghan refugee camps to determine infec-
tion and exposure to both Plasmodium falciparum and Plasmodium vivax. Factors associated with malaria infection 
and exposure were analysed using logistic regression, and spatial heterogeneity within camps was investigated with 
SatScan.
Results: In this low-transmission setting, prevalence of infection in the five camps ranged from 0–0.2 to 0.4–9 % by 
rapid diagnostic test and 0–1.39 and 5–15 % by polymerase chain reaction for P. falciparum and P. vivax, respectively. 
Prevalence of anti-malarial antibodies to P. falciparum antigens was 3–11 and 17–45 % for P. vivax antigens. Significant 
foci of P. vivax infection and exposure were detected in three of the five camps. Hotspots of P. falciparum were also 
detected in three camps, only one of which also showed evidence of P. vivax hotspots.
Conclusions: There is low and spatially heterogeneous malaria transmission in the refugee camps in northern Paki-
stan. Understanding malaria risk in refugee camps is important so the malaria risk faced by these populations in the 
camps and upon their return to Afghanistan can be effectively managed.
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Background
Prior to the conflict, Afghanistan had an effective 
malaria control programme with a focus on vector 
control, with transmission maintained at very low lev-
els [1, 2]. In 1978, a large number of Afghan refugees 
migrated to areas in Pakistan, including Khyber Pakh-
tunkhwa (KP), and settled in camps, some of which are 
in areas capable of supporting malaria transmission [3]. 
The influx of a large and immunologically naïve popu-
lation led to malaria epidemics in the refugee camps in 
1997 and 2002 prompting a focus on providing effective 
malaria control programmes [3–6]. Malaria control pro-
grammes established in the refugee camps included dis-
tribution of insecticide-treated bed nets (ITNs), indoor 
residual spraying (IRS) and free malaria testing and treat-
ment [6–8]. The malaria control efforts led to a decline 
in the reported burden of malaria in the refugee camps 
and, under control, transmission was maintained at low 
endemic levels [5, 9].
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The state of malaria infection and exposure in this ref-
ugee population after residing in northern Pakistan has 
received little attention in recent times as well as which 
diagnostic tool is most suited to such low-transmission 
settings [10, 11]. As health services are scaled down, 
there is a risk that malaria will re-emerge in the camps 
[12–14]. Furthermore, as refugees are repatriated to 
Afghanistan, a country that is rebuilding public health 
infrastructure, there may be the potential to introduce 
transmission if individuals are relocated to receptive 
areas. Conversely, there is a risk of epidemics if a large 
immunologically naïve population is relocated to an area 
with ongoing malaria transmission [15].
To provide current data to inform decision-making 
for managing malaria in this vulnerable population, a 
malariometic survey was conducted in five Afghan refu-
gee camps in northern Pakistan to: (1) assess the utility of 
diagnostic tools in this low-transmission setting, includ-
ing rapid diagnostic test (RDT), polymerase chain reac-
tion (PCR) and the presence of anti-malarial antibodies 
for Plasmodium vivax and Plasmodium falciparum; (2) 
identify factors associated with a current infection as well 
as exposure to P. vivax and P. falciparum in a stable refu-
gee population; and, (3) to identify any spatial patterns 
of malaria present within the Afghan refugee camps in 
Pakistan.
Methods
Study area and sampling
Study participants were selected from five Afghan refugee 
camps in Mardan (Baghecha, Kaghan and Jalala camps) 
and Peshawar (Adezai) districts in the province of Khyber 
Pakhunkwa (KPK) in Pakistan, as well as the Zangal Patai 
camp in the Malakand agency tribal area (Fig. 1). Camps 
were established in the late 1980s with some refugees 
being resident for more than 30 years at the time of the 
survey. The surveys took place between 24 June and 19 
September, 2010 to coincide with the main P. vivax trans-
mission season and before the P. falciparum transmis-
sion season, which typically peaks in late October [5, 9, 
16]. The main vectors in the area are Anopheles stephensi 
and Anopheles culicifacies and the majority of the malaria 
infections are due to P. vivax [4]. The area is characterized 
by sandy and marshy land and is well irrigated for sugar 
cane, wheat and rice production. Houses are primarily 
constructed with rocks, bricks and mud and animal own-
ership is common. Free primary health care is provided at 
basic health units (BHUs) established in each camp and 
run by the UN High Commissioner for Refugees. Malaria 
testing and treatment of microscopically confirmed cases 
is provided free according to national guidelines [15].
Sample size calculations for the survey were 
derived based on estimating anti-malarial antibody 
seroconversion rates (λ) of 0.01 with a residual stand-
ard deviation less than 0.25, which resulted in a sam-
ple of three people per household with a minimum of 
167 households [17, 18]. A numbered list of all current 
households was obtained for each camp and the total 
number of people per age group in each household was 
recorded to provide a sampling weight for the data. Two-
hundred households per camp were randomly selected to 
allow for refusal and absenteeism. One person from each 
of three age groups (one to five, six to 20 and >21 years) 
per household was randomly selected for collection of 
blood samples.
The household heads in all selected households were 
approached for written informed consent and ques-
tionnaires were administered to collect information 
on household characteristics, including wealth indices, 
travel history, malaria control behaviour, and demo-
graphic information. Finger-prick blood samples were 
collected on Whatman 3  mm filter paper (Maidstone, 
UK) from the selected individuals for subsequent labo-
ratory analysis after written consent was obtained. The 
CareStart Pf/Pv combo (Access Bio, Inc. NJ, USA) RDT 
was performed to detect current malaria infections with 
P. vivax (pLDH) and/or P. falciparum (HRP2). All indi-
viduals found to be RDT positive were referred to a BHU 
for full evaluation and for appropriate treatment. Blood 
was also collected onto Whatman 3  mm filter paper 
(Maidstone, UK) for laboratory analysis.
Laboratory analysis
Filter-paper blood spots were dried in the field and stored 
with desiccant at −20  °C and shipped to London for 
analysis. Antibodies to P. falciparum and P. vivax Apical 
Membrane Antigen-1 (AMA-1) and Merozoite Surface 
Protein-119 (MSP-1) were detected using enzyme-linked 
immunosorbent assay (ELISA) as previously described 
[11]. In each camp, individuals positive by RDT and a 
random selection of 120 RDT-negative individuals were 
assayed by a nested, species-specific PCR as previously 
described [19]. Due to the higher malaria prevalence 
observed in Jalala camp, all samples were analysed by 
PCR. Briefly, DNA was extracted using chelex-saponin 
and genus-specific primers were used in the nest-1 reac-
tion and two separate nest-2 reactions were conducted 
using primers specific for P. vivax and P. falciparum.
Statistical analysis
Data analysis was conducted using Stata v12.0 (Stata 
Corp LP, TX, USA) and R v3.2 (R-Project, USA) statistical 
software. Duplicate ELISA OD values were averaged and 
normalized against the positive control sample on each 
plate. OD data were then converted to antibody titres, 
expressed in arbitrary units (AU/ml), using a standard 
Page 3 of 11Wahid et al. Malar J  (2016) 15:245 
curve obtained from hyperendemic control sera. Sero-
positivity was defined by fitting a mixture model to 
normalized OD values [20]. The model assumed two 
Gaussian distributions, one for seronegative values and 
the other seropositive values. The mean OD plus three 
standard deviations of the seronegative values for each 
species and antigen was used as the cut-off value for sero-
positivity. An individual was considered to be seroposi-
tive if they responded to at least one of the two antigens 
tested for each species [21]. Seroprevalence was stratified 
into age groups and the seroconversion rate (SCR) was 
estimated by fitting a reverse catalytic conversion model 
under a binomial sampling assumption [17]. PCR preva-
lence was calculated using a bootstrap approach to avoid 
bias associated with the sampling approach. Briefly, a 
subset of samples assayed by PCR was randomly selected 
with replacement according to RDT positivity. PCR prev-
alence of the sample was determined and repeated 10,000 
times. The mean of the bootstrapped estimates provided 
the overall PCR prevalence per camp and 95  % confi-
dence intervals were calculated according to the Chen-
Shao method [22].
Principal component analysis was used to generate a 
score for socio-economic status (SES) based on house-
hold asset ownership data and grouped according to 
quintiles [23]. Logistic regression was used to assess 
risk factors for both P. falciparum and P. vivax using the 
survey command, weighted for household population 
size, and adjusting for clustering within camps. Spear-
man’s rank correlation coefficient was calculated to 
compare diagnostic tools within camps. Hotspots were 
determined assuming a Bernoulli model with SatScan 
software v9.2 (Harvard, Boston, USA). Elliptical and 
circular windows were used allowing for a maximum 
spatial cluster size of both 50 and 25  % of the popula-
tion at risk. Those households showing evidence of a 
significantly (p  <  0.05) increased prevalence compared 
to the rest of the camp by any of the scans were con-
sidered to be part of a hotspot [11, 24]. Separate scans 
were conducted for sero- and RDT positivity for both P. 
vivax and P. falciparum and results were analysed using 
ArcGis v10.2 (ESRI, CA, USA). Due to the sub-set of 
samples analysed, spatial analysis was not conducted on 
PCR results.
Fig. 1 Study area with the location of the five Afghan refugee camps in Pakistan selected for this survey. National Geographic basemap source: Esri, 
DeLorme, HERE, UNEP-WCMC, USGS, NASA, ESA, METI, NRCAN, GEBCO, NOAA, iPC
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Ethical approval
Ethics approval for the study was granted by both Pesha-
war University (#02/EC/Pharm) and the London School 
of Hygiene and Tropical Medicine (#5715). Individual 
written informed consent was sought from heads of 
included households, and from all selected participants 
by signature. Consent for children under the age of 18 
was provided by a parent/guardian.
Results
In total, 2522 people were sampled in 845 households 
across the five refugee camps (Table 1). Reported bed net 
use the previous night in camps ranged between 3.2  % 
(95 % CI 1.6–4.7 %) of those sampled in Jalala camp and 
63.7 % (95 % CI 59.5–67.9 %) in Baghicha. Reported IRS 
in the previous 12 months (≤10.4 %) and fever in the pre-
vious 2 weeks (≤10.0 %) was low across all camps.
Estimates of malaria infection and exposure were 
consistent with low endemicity in all camps (Table  2). 
Seroprevalence for P. vivax ranged from 47.5  % (95  % 
CI 43.1–51.9  %) in Jalala camp and 17.6  % (95  % CI 
14.2–20.9  %) in Adezai. Similarly, PCR prevalence was 
highest in Jalala with 15.6 % (95 % CI 12.5–18.6 %) for P. 
vivax malaria and the lowest in Kagan with 3.7 % (95 % 
CI 0–6.2  %). Plasmodium vivax infection by RDT was 
lower than PCR: Jalala camp reported the highest RDT 
prevalence at 9.7 % (95 % CI 7.1–12.3 %) and lowest was 
in Adezai camp (0.4; 95 % CI 0–0.9 %). Overall, P. falci-
parum infection and exposure was lower than that of P. 
vivax. Seroprevalence estimates ranged from 9.9 % (95 % 
CI 7.2–12.5  %) in Zangla Patai to 2.4  % (95  % CI 1.1–
3.8 %) in Kagan refugee camp. Evidence of P. falciparum 
infection by PCR was only observed in Jalala (1.4, 95 % CI 
0.6–2.6 %) and Kagan (0.8, 95 % CI 0–2.3 %) camps and 
by RDT in Zangal Patai (0.2, 95 % CI 0–0.65 %).
Plasmodium vivax transmission intensity, as estimated 
by SCR, followed a similar pattern to other infection 
metrics in that it was comparatively low in all camps 
with the highest SCR observed in Jalala camp (0.062, 
95 % CI 0.054–0.073) and lowest in Adezai (0.016, 95 % 
CI 0.013–0.020) (Table  2). Even with the small sample 
size, there was a moderate correlation between the rank-
ing of camps transmission intensity according to P. vivax 
SCR and both PCR (r = 0.6; p = 0.28) and RDT (r = 0.7; 
p = 0.19). PCR bootstrapping estimates correctly classi-
fied Jalala as having the highest transmission but Adezai 
was estimated to have higher PCR prevalence than both 
Kagan and Zangal Patai despite the lowest SCR. SCR 
estimates for P. falciparum suggest residual very low level 
exposure is occurring in all camps, however despite an 
indication of limited transmission, Jalala and Kagan as 
well as Zangal Patai had evidence of current infection 
based on PCR and RDT.
In adjusted analysis for factors associated with P. 
vivax RDT positivity, adults over 20  years of age were 
significantly less likely (OR 0.29, 95  % CI 0.15–0.57) to 
have an infection compared to children under 5  years 
of age (Table  3). Reduced prevalence of being infected 
with P. vivax was seen in those who had been living in 
the camp for the last 6 months compared to arriving in 
Table 1 Demographics by camp
N The number of people sampled/the total number of people in sampled households
Adezai Baghicha Jalala Kagan Zangal Patai
% 95 % CI % 95 % CI % 95 % CI % 95 % CI % 95 % CI
N
 <5 169/1323 169/1112 167/1205 161/957 169/1597
 5–20 171/1548 170/1961 170/1343 168/1946 168/1590
 >20 167/1632 168/1220 168/1458 167/1232 170/1990
 Sex—% male 39.8 35.6–44.1 40.2 35.9–44.5 35.2 31.1–39.4 41.9 37.6–46.3 47.5 43.2–51.9
 Camp resident 6 months 9.1 6.6–11.6 2.6 1.2–3.9 3.2 1.6–4.7 15.1 11.9–18.3 2.2 1.0–3.4
 Travel 3 months 14.0 11.0–17.0 14.8 11.7–17.9 11.9 9.0–14.7 11.3 8.5–14.1 21.3 17.7–24.9
 Fever 2 weeks 1.8 0.6–3.0 10.0 7.4–12.7 7.1 4.9–9.4 2.8 1.4–4.3 2.6 1.2–3.9
 ITN last night 16.0 12.8–19.2 63.7 59.5–67.9 3.2 1.6–4.7 51.4 47.0–55.8 9.3 6.7–11.8
 IRS 12 months 4.1 2.4–5.9 2.4 1.0–3.7 7.7 5.4–10.0 2.4 1.1–3.8 10.4 7.8–13.1
SES
 1 22.0 18.4–25.6 21.9 18.3–25.5 29.9 25.9–33.9 21.8 18.1–25.4 16.0 12.8–19.2
 2 16.1 12.8–19.3 18.3 15.0–21.7 8.9 6.4–11.4 27.0 23.1–30.9 12.4 9.5–15.3
 3 19.0 15.6–22.5 30.4 26.3–34.4 11.3 8.5–14.0 16.9 13.6–20.2 11.8 9.0–14.6
 4 20.8 17.3–24.4 18.9 15.5–22.3 23.2 19.5–26.8 22.4 18.7–26.0 19.5 16.1–23.0
 5 22.0 18.4–25.6 10.4 7.8–13.1 26.7 22.8–30.6 11.9 9.0–14.7 40.2 35.9–44.5
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the camp more recently (OR 0.18, 95  % CI 0.05–0.71). 
Those reporting a fever in the previous 2 weeks had over 
seven times the odds (OR 7.03, 95  % CI 3.47–14.26) of 
being infected compared to those not reporting a fever. 
Both reported use of an ITN the previous night and use 
of mosquito repellants in the household were associated 
with a reduced odds of having a P. vivax infection while 
those of higher SES were also less likely to be infected 
(Table 3).
As expected, both P. vivax and P. falciparum seropreva-
lence increased with age: those 20 years of age and older 
had 7.28 (95 % CI 5.61–9.45) and 2.73 (95 % CI 1.69–4.39) 
the odds of being positive for anti-malarial antibodies 
to P. vivax and P. falciparum, respectively, compared to 
those younger than 5 years. Those reporting fever in the 
previous 2 weeks also had increased odds of being sero-
positive for both P. vivax (OR 3.29, 95  % CI 2.20–4.91) 
and P. falciparum (OR 1.99, 95 % CI 1.05–3.77). Reported 
use of mosquito repellents was associated with a 30  % 
reduction in odds of exposure for both species (Table 4). 
Being a resident in the camp for the 6 months prior to the 
survey was associated with a significant reduction (OR 
0.15, 95 % CI 0.05–0.42) whereas having reported to have 
travelled in the past three months was associated with 
increased P. falciparum seroprevalance (OR 1.99, 95 % CI 
1.05–3.77). Living in a household with an iron roof was 
associated with an increase in odds with being seroposi-
tive to P. falciparum (OR 1.63, 95 % CI 1.04–2.55). Own-
ing animals showed a 1.63 (95 % CI 1.30–2.05) increase 
in the odds of being seropositive for P. vivax compared 
to not owning any animals but had no association with P. 
falciparum.
Evidence of spatial clustering of both infection and 
exposure to P. vivax was observed in three of the five 
refugee camps (Fig. 2). In Jalala camp, where estimates of 
P. vivax transmission was the highest, 51.3 % of sampled 
households were found to be part of a hotspot by at least 
one metric and 17.8  % of households showing evidence 
of significant clustering for all markers (Fig.  2c). Baghi-
cha (Fig. 2b) and Kagan (Fig. 2d) showed no evidence of 
spatial clustering for P. vivax whereas hotspots consisting 
of 14.8 % of households in Adezai (Fig. 2a) and 28.4 % in 
Table 2 Malaria outcomes per camp
Adezai Baghicha Jalala Kagan Zangal Patai
% 95 % CI % 95 % CI % 95 % CI % 95 % CI % 95 % CI
P. vivax
 SCR 0.016 0.013–0.020 0.036 0.031–0.043 0.063 0.054–0.073 0.029 0.025–0.035 0.017 0.014–0.021
 Seroprevalence 17.6 14.2–20.9 32.5 28.4–36.6 47.5 43.1–51.9 28.9 24.9–32.9 19.1 15.7–22.6
 PCR 7.0 3.7–11.7 9.1 4.4–13.9 15.6 12.5–18.6 3.7 0–6.2 6.9 2.8–10.6
 RDT 0.4 0–0.9 2.8 1.3–4.2 9.7 7.1–12.3 2.0 0.8–3.2 4.1 2.4–5.9
P. falciparum
 SCR 0.002 0.002–0.004 0.007 0.005–0.009 0.003 0.002–0.005 0.002 0.001–0.003 0.008 0.006–0.011
 Seroprevalence 3.2 1.6–4.7 9.1 6.6–11.6 4.5 2.7–6.4 2.4 1.1–3.8 9.9 7.2–12.5
 PCR 0 0 1.4 0.6–2.6 0.8 0–2.3 0
 RDT 0 0 0 0 0.2 0–0.6
Table 3 Factors associated with  Plasmodium vivax infec-
tion by RDT
* p < 0.0001, ** p < 0.01, *** p < 0.05
RDT
Univariate Multivariate
OR 95 % CI OR 95 % CI
Age group (years)
 ≤5 1 – 1 –
 6–20 0.80 0.50–1.28 0.71 0.42–1.20
 >20 0.36** 0.20–0.68 0.29* 0.15–0.57
 Sex—male 1.64 0.99–2.69
 Camp resident 6 months 0.14*** 0.03–0.67 0.18*** 0.05–0.71
 Travel 3 months 1.02 0.53–1.94
 Fever—2 weeks 6.35* 3.57–11.31 7.03* 3.47–14.26
 Sought malaria treatment 2.48*** 1.13–5.47
 IRS 12 months 0.41 0.10–1.59
 ITN last night 0.18** 0.07–0.47 0.14* 0.05–0.39
 Use repellants 0.30* 0.17–0.50 0.29* 0.17–0.50
 Roof—iron 0.36** 0.19–0.68
 Eaves—closed 0.54*** 0.30–0.98
 Animal ownership 1.28 0.77–2.14
SES
 1 1 – 1 –
 2 0.39*** 0.16–0.95 0.43 0.18–1.06
 3 0.59 0.28–1.25 0.62 0.26–1.46
 4 0.48*** 0.24–0.97 0.55 0.28–1.10
 5 0.15* 0.07–0.32 0.15* 0.07–0.32
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Zangal Patai (Fig. 2e) were identified. Evidence of cluster-
ing of P. falciparum seroprevalence (Fig. 3) were observed 
in Bachicha (Fig.  3b), Kagan (Fig.  3d) and Zangal Patai 
(Fig. 3e) camps with hotspots comprising of 34.5, 7.1 and 
4.1 % of sampled households, respectively.
Discussion
This study shows evidence of comparatively low and 
highly heterogeneous transmission for both P. vivax and 
P. falciparum in five Afghan refugee camps in Pakistan. 
Plasmodium vivax infections were detected in all camps 
by both RDT and PCR and ranked camps in order of 
transmission intensity similarly to the order quantified by 
SCR. No P. falciparum infections by either RDT or PCR 
were detected in two of the camps although there was 
evidence of low transmission detected through serologi-
cal tools. The limited sensitivity of diagnostic tools for 
current infection observed in this very low-transmission 
setting is consistent with other studies and further high-
lights the importance in having combined diagnostic 
approaches to ensure that current infections as well as 
transmission potential are included in decision-making 
[11, 25]. In the camps in this study, combining sensitive 
PCR with serological methods generated a more com-
plete picture of where transmission is occurring and thus 
areas of risk that control programmes might effectively 
target [10].
Several factors associated with infection and exposure 
to P. vivax as well as exposure to P. falciparum were iden-
tified in this stable refugee population. The use of mos-
quito repellants, such as sprays or coils, were consistently 
associated with a reduction in odds of both infection 
and exposure. This finding may be related to the limited 
reported use of IRS and ITNs in some of the camps and 
conversely, the availability and ease of use of repellents. It 
may also reflect increased awareness of malaria by those 
that use repellents. Continuing to promote and ensure 
the availability of mosquito repellents in addition to ITNs 
or providing these tools as part of a repatriation package 
upon returning to Afghanistan could be a useful and sim-
ple addition to malaria control programmes [26].
Residing in the camp for the previous 6 months was asso-
ciated with a significant reduction in the odds of malaria 
exposure whereas recent travel showed increased odds. 
These findings suggest that importation of malaria from 
other areas may be contributing to the maintenance of 
Table 4 Factors associated with Plasmodium vivax and Plasmodium falciparum seropositivity as a marker for exposure
* p < 0.0001, ** p < 0.01, *** p < 0.05
P. vivax P. falciparum
Univariate Multivariate Univariate Multivariate
OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI
Age group (years)
 ≤5 1 – 1 – 1 – 1 –
 6–20 1.89* 1.44–2.47 1.91* 1.44–2.53 1.93*** 1.15–3.23 1.87*** 1.11–3.15
 >20 7.28* 5.61–9.45 7.67* 5.83–10.10 3.05* 1.90–4.91 2.73* 1.69–4.39
 Sex—male 0.60* 0.49–0.74 1.02 0.70–1.48
 Camp resident 6 months 0.29 0.08–1.13 0.11* 0.04–0.28 0.15* 0.05–0.42
 Travel 3 months 1.93* 1.50–2.49 1.95** 1.31–2.91 1.55*** 1.04–2.29
 Fever 2 weeks 3.18* 2.21–4.57 3.29* 2.20–4.91 2.03*** 1.08–3.82 1.99*** 1.05–3.77
 IRS 12 months 1.30 0.78–2.14 1.51 0.60–3.79
 ITN last night 0.88 0.23–1.08 1.36 0.87–2.11
 Use mosquito repellants 0.69* 0.58–0.81 0.68* 0.56–0.82 0.64*** 0.44–0.91 0.65*** 0.45–0.94
 Sought malaria treatment 3.47* 2.33–5.17 2.06*** 0.99–4.24
 Roof—iron 0.91 0.73–1.15 1.58*** 1.02–2.45 1.63*** 1.04–2.55
 Eaves—closed 0.92 0.74–1.14 0.70 0.45–1.06
 Animal ownership 1.58* 1.29–1.93 1.63* 1.30–2.05 0.86 0.57–1.30
SES
 1 1 – 1 –
 2 0.77 0.56–1.06 0.90 0.47–1.71
 3 1.03 0.76–1.41 1.03 0.55–1.92
 4 1.20 0.89–1.61 0.68 0.34–1.36
 5 0.96 0.71–1.31 1.35 0.73–2.50
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malaria transmission within these camps [27]. This study 
did not collect the location of travel, which would be use-
ful in ascertaining whether travel is to high-risk areas or if 
this association is confounded by other factors. The role of 
importation sustaining transmission in low-endemic areas 
has been observed in other areas. For example, in Swaziland, 
a recent survey found that a single P. falciparum-infected 
individual had reported recent travel to Mozambique where 
malaria transmission is still high [28]. Additional risk factors 
such as age, regions or villages visited, or employment type, 
Fig. 2 Results of spatial clustering using multiple outcomes. For Plasmodium vivax (seropositivity, RDT positivity) for Adezai (a), Baghicha (b), Jalala 
(c), Kagan (d), and Zangal Patai (e) refugee camps as estimated from SatScan. Blue dots are households that were not part of a hotspot; green and 
orange dots were part of a significant hotspot of seropositivity and RDT, respectively; red dots were households found to be part of a hotspot using 
both sero- and RDT-positivity. World Imagery basemap source: Esri, DigitalGlobe, GeoEye, i-cubed, USDA, FSD, USGS, AEX, Getmapping, Aerogrid, 
IGN, IGP, swisstopo, and the GIS User Community
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associated with importation as well as the potential for initi-
ating transmission chains would help to guide effective con-
trol programmes in these populations [29]. Furthermore, 
how to most effectively target this population as well as 
those at high risk for sustaining transmission (e.g. household 
members of travelers) as well as the impact of such efforts 
could provide useful strategies and should be explored. Sim-
ilarly, by analysing travel behaviour and identifying time and 
location of most frequent travel could provide novel popula-
tion for which to target interventions.
Fig. 3 Results of spatial clustering using multiple outcomes. For P. falciparum (seropositivity) for Adezai (a), Baghicha (b), Jalala (c), Kagan (d), and 
Zangal Patai (e) refugee camps as estimated from SatScan. Blue dots are households that were not part of a hotspot and red dots were households 
found to be part of a hotspot of seropositivity. World Imagery basemap source: Esri, DigitalGlobe, GeoEye, i-cubed, USDA, FSD, USGS, AEX, Getmap-
ping, Aerogrid, IGN, IGP, swisstopo, and the GIS User Community
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Owning animals was associated with increased odds 
of being seropositive for P. vivax but was not associated 
with exposure to P. falciparum. Different Anopheline vec-
tor species have been identified in Afghan refugee camps 
and it is likely that they have different blood-feeding 
behaviours [8]. However, the lack of association to P. fal-
ciparum exposure may also be due to low levels of sero-
reactivity observed which is likely a product of the low 
levels of infections, but also due the differences in the 
timing of sampling in relation to the sampling with the 
survey taking place after the main P. vivax season and 
before the P. falciparum one.
Finally, a history of fever was associated with both 
increased odds of P. vivax infection and exposure to P. 
vivax and P. falciparum. The association with malaria is 
well known and serves as a useful symptom with which 
to identify malaria infection. Targeting efforts to areas 
with a high occurrence of fever could provide a simple 
indicator to initiate re-active case detection, or targeting 
populations reporting a higher incidence of fever. How-
ever, due to the non-specific nature of using fever to diag-
nose malaria, particularly in low transmission settings, 
this approach would need to be validated or be accom-
panied by a malaria diagnostic tool to confirm infection.
There are a number of limitations to this study. Firstly, 
the camps were sampled at different time points in the 
transmission season with Baghicha and Kagan sampled 
before and Adezai, Jalala and Zangal patai sampled dur-
ing the main P. vivax transmission season. This may have 
had some impact on the ability to correctly rank trans-
mission intensity with the different metrics. RDT positiv-
ity for example, may persist after infection and this will 
be more likely to occur at the end of the transmission 
season. However, the low seroprevalence and SCR sug-
gest that seasonal effects on prevalence will be minimal.
The very low P. falciparum prevalence may have been 
the result of sampling all camps prior to the main trans-
mission season, which typically occurs in October [5]. 
However, the ability to correctly distinguish areas with 
transmission potential during the period of low transmis-
sion is likely more powerful to detect residual foci that 
would seed the upcoming transmission season and there-
fore provides valuable insight.
PCR could only be conducted on a sub-set of samples 
due to time and financial constraints. Whilst bootstrap-
ping techniques were used to obtain population level 
prevalence estimates, these could not be used to assess 
risk factors or spatial patterns of infection. The factors 
associated with current infection are not expected to 
have varied significantly as findings are consistent with 
previous studies in the Afghan refugee population as well 
as other studies in low transmission settings [8, 30, 31]. 
For example, a study by Sangoro et al. showed that in an 
epidemic setting, people not using repellents had eight 
times the odds of being infected, and ITN use has long 
been associated with protection from malaria [32, 33]. 
Finally, in the case of P. vivax it is unclear if the infec-
tion and exposure dynamics described are the result of de 
novo infection or transmission maintained by hypnozo-
ite-derived infections. This is common with most studies 
on P. vivax as there is no diagnostic to identify hypnozo-
ite infections. It is possible that elevated antibody levels 
in the absence of an infection could be used to indicate 
the possibility of hypnozoite carriage but this needs to be 
validated in individuals with known relapses, and with 
probability a broader range of antigenic targets.
This study suggests that there are low levels of both P. 
vivax and P. falciparum transmission occurring in the 
refugee camps included in this survey. However, although 
risk is low, it is still higher than reports from the rest 
of KPK, which suggest 1 % prevalence by RDT [34, 35]. 
The higher levels of malaria risk observed in the camps 
is likely a factor of where the camps were located, in 
areas known to support malaria transmission [3]. Pro-
vincial estimates, including a larger range of regions of 
both rural and urban areas, would mask heterogeneity of 
transmission and bias estimates towards the null. Recent 
reports of emerging multidrug-resistant P. falciparum 
strains in Pakistan [36] as well as reports of the presence 
of sub-standard anti-malarial drugs in Afghanistan are 
cause for concern [37]. The proportionally large amount 
of infected individuals in the refugee camps and the pro-
posed repatriation of all refugees to Afghanistan by the 
end of 2015 could result in a large movement of parasites 
to a setting that may exacerbate the problem and fuel the 
spread of multidrug-resistant malaria in the region [38].
Conclusions
Ultimately, understanding the epidemiology behind 
malaria transmission in this vulnerable population is 
essential so that malaria control programmes can effec-
tively target their resources where they can be most 
effective [39]. As health services in the refugee camps 
are scaled back and the refugee populations continue to 
move back to their native Afghanistan, understanding the 
risk to this migrant population of malaria infection and 
the spread of parasites conferring markers of drug resist-
ance is paramount so that a fragile public health infra-
structure will not be overwhelmed.
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